Differential Diagnosis

Medical / Technology / Education feed

Would you pay $1 million to enroll in a phase 1 clinical trial of an

Would you pay $1 million to enroll in a phase 1 clinical trial of an “anti-aging” gene therapy?

"Libella Gene Therapeutics, LLC made the news last week for announcing a “pay-to-play” trial of its telomerase-based anti-aging gene therapy. What was shocking about the announcement was not that it was a “pay-to-play” trial, given that such trials have become all too common, but rather the price of enrollment: $1 million. Worse, the trial is being conducted in Colombia; the therapy doesn’t have the greatest preclinical justification; and it’s a phase 1 trial, which means it is only trial of safety, not efficacy. How can unethical and scientifically dubious trials like this be stopped?"



Source: sciencebasedmedicine.org

trial gene 1 “pay-to-play” phaseclinical enroll $ trials